Vertex Pharmaceuticals, Inc. (VRTX) Reports Q2 Loss of 85c, Beats by 10c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $528.90 --0%
EPS Growth %: 0.0%
Financial Fact:
Cost of product revenues: 53.22M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: 0.0%
Financial Fact:
Cost of product revenues: 53.22M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q2 EPS of ($0.85), $0.10 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $114.42 million, versus $31.62 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
